AstraZeneca (AZN) Broadens AZ&Me Prescription Savings Programs Eligibility
Up)
AstraZeneca (NYSE: AZN) reports it broadened the income eligibility for its AZ&Me Prescription Savings programs to enable more people to qualify for free medicines.
The new annual household income eligibility levels are $35,000 for individuals, $48,000 for couples, $60,000 for a family of three and $70,000 for a family of four.
Those with an annual household income that falls within the new income eligibility guidelines may receive AstraZeneca medicines for free if they meet all program criteria.
Previously, AstraZeneca provided prescription savings benefits to qualified patients with a total yearly income of $30,000 for individuals, $40,000 for couples, $50,000 for a family of three and $60,000 for a family of four.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The new annual household income eligibility levels are $35,000 for individuals, $48,000 for couples, $60,000 for a family of three and $70,000 for a family of four.
Those with an annual household income that falls within the new income eligibility guidelines may receive AstraZeneca medicines for free if they meet all program criteria.
Previously, AstraZeneca provided prescription savings benefits to qualified patients with a total yearly income of $30,000 for individuals, $40,000 for couples, $50,000 for a family of three and $60,000 for a family of four.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Royalty Pharma Raises $600 Million of Debt
- Chesapeake (CHK) Shares Surge Amid Report Icahn Now 'Major' Holder
- Apple (AAPL) Amends RSU Award Agreements in Lieu of Upcoming Dividend; CEO Cook Defers
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
